Hepatic histopathological changes and dysfunction in primates following exposure to organic arsenic diphenylarsinic acid

DOI IR HANDLE Web Site Web Site View 1 Remaining Hide 21 References Open Access
  • Masuda Tomoyuki
    Department of Neurology, Faculty of Medicine, University of Tsukuba Department of Neurobiology, Faculty of Medicine, University of Tsukuba
  • Ishii Kazuhiro
    Department of Neurology, Faculty of Medicine, University of Tsukuba
  • Morishita Yukio
    Department of Diagnostic Pathology, Tokyo Medical University Ibaraki Medical Center
  • Iwasaki Nobuaki
    Department of Pediatrics, Ibaraki Prefectural University of Health Sciences
  • Shibata Yasuyuki
    Center for Environmental Measurement and Analysis, National Institute for Environmental Studiesan
  • Tamaoka Akira
    Department of Neurology, Faculty of Medicine, University of Tsukuba

Search this article

Abstract

<p>Organic arsenic diphenylarsinic acid (DPAA[V]) accumulates at high concentrations in the liver of primates after its subchronic administration. However, no studies on the hepatic effects of organic arsenic compounds, including DPAA(V), on primates have been reported to date. To clarify the toxicokinetics of DPAA(V) in the liver of primates, hepatic tissue specimens were collected from cynomolgus monkeys (n = 32) at 5, 29, 170, and 339 days after repeated administration of DPAA(V) for 28 days. Four histopathological changes in the specimens were observed and pathologically evaluated. Atypical ductular proliferation was found in the DPAA(V)-exposed liver throughout the period. Inflammatory cell infiltration in Glisson’s capsules and lipid droplets were seen at earlier periods after administration. Conversely, inflammatory cell infiltration in liver lobules was seen later after administration. In this experiment, we did not confirm the hepatic dysfunction of DPAA(V)-exposed monkeys by blood chemistry tests. To compensate for this, we further investigated the blood from a patient who exhibited several neurological symptoms after DPAA(V) exposure. Her blood chemistry test values for aspartate transaminase, alanine transaminase, and lactate dehydrogenase were elevated, suggesting that her liver may have been damaged by DPAA(V) exposure. Together, these findings suggest that the accumulation of DPAA(V) may induce differential histopathological changes in primate hepatocytes, resulting in decreased liver function. This is the first report to investigate the liver of primates pathologically after exposure to organic arsenic DPAA(V). Our findings will help expand our knowledge regarding the effect of DPAA(V) on the liver of primates.</p>

Journal

References(21)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top